Dimitrios Ziogas

    My co-authors include

    George Bakalos
    Dr Beatriz Gras-Miralles
    Kathryn T Hall

    My Publications

    Vulnerability variables among octogenerian myeloma patients: a single-center analysis o...

    • Leukemia & Lymphoma
    • January 2019

    Prognostic factors for multiple myeloma in the era of novel therapies

    • Expert Review of Hematology
    • October 2018

    Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis

    • Amyloid
    • October 2018

    Treating ALK-positive non-small cell lung cancer

    • Annals of Translational Medicine
    • April 2018

    Breakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibli...

    • Annals of Translational Medicine
    • April 2018

    Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in ...

    • Blood
    • January 2018

    POEMS Syndrome

    • January 2018

    The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can ove...

    • Blood
    • November 2017

    An overview of the role of carfilzomib in the treatment of multiple myeloma

    • Expert Opinion on Pharmacotherapy
    • November 2017

    Gefitinib: an “orphan” drug for non-small cell lung cancer

    • Expert Opinion on Orphan Drugs
    • October 2017

    Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (an...

    • Leukemia & Lymphoma
    • August 2017

    Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, import...

    • Blood Cancer Journal
    • June 2017

    Circulating autoantibodies to endogenous erythropoietin are associated with chronic hep...

    • Hepatobiliary & Pancreatic Diseases International
    • June 2017

    Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and ...

    • American Journal of Hematology
    • May 2017

    Bortezomib and Lenalidomide (VR) Consolidation Post-ASCT without Dexamethasone and Bisp...

    • Clinical Lymphoma Myeloma & Leukemia
    • February 2017

    Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma

    • European Journal of Gastroenterology & Hepatology
    • January 2017

    Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after...

    • Leukemia & Lymphoma
    • December 2016

    When to recommend a second autograft in patients with relapsed myeloma?

    • Leukemia & Lymphoma
    • November 2016

    Evaluation of the Revised International Staging System in an independent cohort of unse...

    • Haematologica
    • October 2016

    Evaluation of the Revised International Staging System (R-ISS) in an Independent Cohort...

    • Clinical Lymphoma Myeloma & Leukemia
    • September 2016

    Carfilzomib for treating myeloma

    • Expert Opinion on Orphan Drugs
    • August 2016

    Increased circulating VCAM-1 correlates with advanced disease and poor survival in pati...

    • Blood Cancer Journal
    • May 2016

    Bortezomib-based triplets are associated with a high probability of dialysis independen...

    • American Journal of Hematology
    • April 2016

    Predicting the Outcome of Sjogren’s Syndrome-Associated Non-Hodgkin’s Lymphoma Patients

    • PLoS ONE
    • February 2015

    Asymptomatic Bacteriuria in Women With Autoimmune Rheumatic Disease: Prevalence, Risk F...

    • Clinical Infectious Diseases
    • November 2014

    Inflammation-induced functional connectivity of melanin-concentrating hormone and IL-10

    • Peptides
    • May 2014

    Intestinal Upregulation of Melanin-Concentrating Hormone in TNBS-Induced Enterocolitis ...

    • PLoS ONE
    • December 2013

    Anti-melanin-concentrating hormone treatment attenuates chronic experimental colitis an...

    • AJP Gastrointestinal and Liver Physiology
    • May 2013

    Increased Susceptibility of Melanin-Concentrating Hormone-Deficient Mice to Infection w...

    • Infection and Immunity
    • October 2012

    Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritabl...

    • PLoS ONE
    • October 2012

    Reduced Intestinal Tumorigenesis in APCmin Mice Lacking Melanin-Concentrating Hormone

    • PLoS ONE
    • July 2012

    The reporting quality of studies investigating the diagnostic accuracy of anti-CCP anti...

    • BMC Musculoskeletal Disorders
    • June 2012

    FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic ...

    • Biomarkers
    • June 2012

    Variants of the MTHFR gene and susceptibility to acute lymphoblastic leukemia in childr...

    • Cancer Epidemiology
    • April 2012

    Evidence of Association BetweenMethylenetetrahydrofolate ReductaseGene and Susceptibili...

    • DNA and Cell Biology
    • February 2012

    Bone mineral density and genetic markers involved in three connected pathways (focal ad...

    • Biomarkers
    • November 2011

    Oxidative stress and inflammatory markers in the exhaled breath condensate of children ...

    • Sleep And Breathing
    • August 2011

    A Network Meta-analysis of Randomized Controlled Trials of Induction Treatments in Acut...

    • Clinical Therapeutics
    • March 2011

    You deserve what you eat: lessons learned from the study of the melanin-concentrating h...

    • Gut
    • October 2010

    T1904 Predictors and Patterns of the Placebo Response in Gastro-Esophageal Reflux Disea...

    • Gastroenterology
    • May 2010

    Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease

    • Alimentary Pharmacology & Therapeutics
    • March 2010

    Field Synopsis and Synthesis of Genetic Association Studies in Osteoarthritis: The CUMA...

    • American Journal of Epidemiology
    • March 2010

    Serum correlates of the placebo effect in irritable bowel syndrome

    • Neurogastroenterology & Motility
    • March 2010

    MTHFRgene polymorphisms and response to chemotherapy in colorectal cancer: a meta-analysis

    • Pharmacogenomics
    • August 2009

    Analysis of the Quality of Reporting of Randomized Controlled Trials in Acute and Chron...

    • Annals of Epidemiology
    • July 2009